Impact of COVID-19 on Economy, Industry and Company :
The emergence of novel coronavirus has affected the global economy, industry dynamics and company’s top line. The entire ecosystem has to suffer the impact of this pandemic disease which would result in significant demand & supply gap, production delay and weak consumer demand of end products across industries. At Bizizz Market Research, our analyst has done extensive research across industries and identify various methodologies which would assist C-Level executive to counter this ongoing threat and make informed business decision.
Kindly contact us to know more details: https://www.bizizzmarketresearch.com/contact
Global Hyperkalaemia Treatment Market was Valued at US$ XX Mn in 2019 and it is Expected to Reach More than US$ XX Mn by 2028, Likely to Grow with the CAGR of 17.1% During the Forecast Period.
A Rising rate of occurrence of acute hyperkalaemia along with a chronic hyperkalaemia is by an increasing geriatric population worldwide. Geriatric population increase with latest technologies is anticipated to substantiate growing occurrence in heart and chronic kidney related illnesses, and a group of patients are anticipated to take risk of hyperkalaemia that is boosting its treatment. Therefore report from the World Population Prospects: of 2017 Revision, the number of geriatric population of an age group of 60 years and above, are anticipated to multiply during the forecast period.
The hyperkalemia was accounted of about 5% of general population, globally. As per the National Kidney Foundation, the heart failure along with chronic kidney disease (CKD) contribution in the occurrence of hyperkalemia could be up to 20%, and it is anticipated with a higher risk of mortality and higher cardiovascular diseases. As per the United States Renal Data System in 2018, the overall occurrence of CKD (Stages 1-5) in adult population of the United States was about 14.8% during the forecast period.
Rising Healthcare Industry in developing countries to drive the Demand for Hyperkalemia Treatment
The healthcare industry is plunging in its market growth because of an increase in the occurrence of the disease and its wide spread. The industry is growing by a rise in the government policies and schemes that are in favor. Moreover, increasing hyperkalaemia treatments globally are also plunging the market growth of Hyperkalaemia treatment globally.
Chronic hyperkalaemia treatment Segment held prominent share in Global Hyperkalemia Treatment Market in 2019
The occurrence of chronic hyperkalemia treatment is leading in the market. Chronic hyperkalemia is actually concerned to an impaired renal excretion. Chronic hyperkalemia is generally a asymptomatic, therefore its treatment goals constitutes of elimination of common symptoms, cardiac dysrhythmias, and leading to death. The treatment of chronic hyperkalemia consists of diuretics, dietary restriction, bicarbonate salts, potassium binders, and dialysis. The chronic hyperkalemia is one of the significant complexities in chronic kidney disease (CKD) that existed frequently and needs good management of nephrologist. Thus it is anticipated to lead the global market during the forecast period.
The North America is expected to dominate the Hyperkalemia Treatment Market during the Forecast Period
The North American region held leading position for hyperkalemia treatment market by an advancement of medical technology and rising aging populations are contributing in an increased occurrence of heart and kidney ailments are significant patients at a risk of hyperkalemia. An estimated 3.7 Mn US adults had encountered hyperkalemia in the year 2014, and its occurrence rate is high since 2010. Patients who are suffering from CKD and other chronic diseases with an increased annual occurrence in hyperkalemia of about 6.35% in 2014, and approximately half of these patients suffering from hyperkalemia have chronic heart or kidney diseases. Higher accessibility of medication, increasing awareness, with suitable reimbursement is vital factors propelling the market growth in the North American region.
Global hyperkalemia treatment market is consolidated with key players holding major share of global hyperkalemia treatment market. Organizations involved in this market are focused on offering advanced treatments of hyperkalemia to compete in the global market.
Key players operating in the global hyperkalemia treatment market are Ardelyx, Sanofi S.A., Vifor Pharma Management Ltd, AstraZeneca Plc, and Perrigo Company plc.
Global Hyperkalemia Treatment Market Key Segments:
Global Hyperkalemia Treatment Market, By Type of Disease
- Acute Hyperkalemia
- Chronic Hyperkalemia
Global Hyperkalemia Treatment Market, By Drug
- Sodium zirconium cyclosilicate
- Beta2 Agonist
- Sodium Polystyrene Sulfonate
Global Hyperkalemia Treatment Market, By Region
- North America
- Asia Pacific
- Middle east and Africa
- Latin America